CLINICAL_TRIALS
trial_result
· 2019-09-30
Clinical Trial Update: Open Label, Adaptive, Parallel Group PET Study Using RO7017773 And [11C] RO15-4513 [Phase 1]
Summary
Phase 1 open-label adaptive study evaluating RO7017773 with [11C] RO15-4513 in Autism Spectrum Disorder has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Hoffmann-La Roche | Conditions: Autism Spectrum Disorder | Phase 1 | Status: COMPLETED | Results posted: 2019-09-30